Employees Retirement System of Texas Raises Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Employees Retirement System of Texas lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 33.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 877,272 shares of the exchange traded fund’s stock after purchasing an additional 220,400 shares during the period. Employees Retirement System of Texas owned approximately 1.15% of SPDR S&P Biotech ETF worth $79,007,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Golden State Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Kohmann Bosshard Financial Services LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Avior Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares in the last quarter. Lee Danner & Bass Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $43,000.

SPDR S&P Biotech ETF Stock Down 5.7 %

Shares of NYSEARCA:XBI opened at $73.66 on Monday. SPDR S&P Biotech ETF has a fifty-two week low of $70.16 and a fifty-two week high of $105.47. The firm’s 50 day moving average price is $88.13 and its 200 day moving average price is $93.12. The stock has a market cap of $4.65 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.